a) US
b) China
c) South Korea
d) India
India has disagreed with the World Health Organisation’s decision to temporarily suspend clinical trials of Hydroxychloroquine for the treatment of COVID-19 patients. India sent a letter to WHO stating that all reports about the safety and efficacy of HCQ have not been considered before giving the decision to put HCQ clinical trial on hold.
